[Federal Register Volume 66, Number 246 (Friday, December 21, 2001)]
[Notices]
[Page 65992]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-31408]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 8, 2001, American 
Radiolabeled Chemical, Inc., 11624 Bowling Green Drive, St. Louis, 
Missouri 63146, made application by renewal and by letter dated May 2, 
2001, to the Drug Enforcement Administration (DEA) for registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)...........  I
Lysergic acid diethylamide (7315)..........  I
Dimethyltryptamine (7435)..................  I
Dihydromophine (9145)......................  I
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Hydromorphone (9150).......................  II
Oxycodone (9143)...........................  II
Thebaine (9333)............................  II
Benzoylecgonine (9180).....................  II
Meperidine (9230)..........................  II
Metazocine (9240)..........................  II
Morphine (9300)............................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to bulk manufacture small quantities of the listed 
controlled substances as radiolabeled compounds.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than February 19, 2002.

    Dated: November 15, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-31408 Filed 12-20-01; 8:45 am]
BILLING CODE 4410-09-M